Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-23T09:10:39.860Z Has data issue: false hasContentIssue false

EPA-1799 – Substance Abuse and Attention Deficit Disorder in the adult - a Case Report

Published online by Cambridge University Press:  15 April 2020

J. Ramos
Affiliation:
Psiquiatria/psychiatry, Hospital Fernando Fonseca, Lisbon, Portugal
S. Xavier
Affiliation:
Psiquiatria/psychiatry, Hospital Fernando Fonseca, Lisbon, Portugal
B. Ferreira
Affiliation:
Psiquiatria/psychiatry, Hospital Fernando Fonseca, Lisbon, Portugal
J. Ramos
Affiliation:
Psiquiatria/psychiatry, Hospital Fernando Fonseca, Lisbon, Portugal
M. Morins
Affiliation:
Psiquiatria/psychiatry, Hospital Fernando Fonseca, Lisbon, Portugal
T. Maia
Affiliation:
Psiquiatria/psychiatry, Hospital Fernando Fonseca, Lisbon, Portugal

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The attention deficit is the main symptom of the Attention Deficit Hyperactivity Disorder (ADHD) in adults. This diagnosis is difficult in adults and comorbidity with substance abuse (SA) is high. As ADHD influences negatively the prognosis of the patients with SA, it is important to treat the ADHD in individuals with DS. Furthermore, it is common the use of substances to relieve ADHD and its comorbidities's symptoms.

It is known the paradoxical effect of amphetamines in individuals with ADHD and it was also described with cocaine. This characteristic is an important clinical clue to the diagnosis of ADHD and it is a predictor of a positive response to the therapeutics.

Goals

It is intended to approach the issues related to the psycopathology, differential diagnosis, prognostic and therapeutic implications when there is comorbidity between ADHD and SA in the adult.

Aims

Therapeutic implications of the comorbidity between ADHD and SA.

Materials and methods

Analyses of a clinical case and a non-systematic review of the literature was made.

Results

A 23-year-old woman, lawyer, has the diagnosis of ADHD since childhood. She regularly used cocaine for the last 2 years, without doing any medication, as she felt quiet, relax and focused, being more productive at work. The treatment with prolonged-release methylphenidate allowed to stop the use of cocaine without a recurrence of cognitive symptoms.

Conclusions

The ADHA is an independent risk factor to the SA; The early detection and treatment of ADHD helps to prevent the substance abuse;

Type
P01 - Addictive Behaviours
Copyright
Copyright © European Psychiatric Association 2014
Submit a response

Comments

No Comments have been published for this article.